Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma-Reference-Cited by-同舟云学术

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Published:2023-12-14 Issue:24 Volume:389 Page:2256-2266
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Hassel Jessica C.¹,Piperno-Neumann Sophie¹,Rutkowski Piotr¹,Baurain Jean-Francois¹,Schlaak Max¹,Butler Marcus O.¹,Sullivan Ryan J.¹,Dummer Reinhard¹,Kirkwood John M.¹,Orloff Marlana¹,Sacco Joseph J.¹,Ochsenreither Sebastian¹,Joshua Anthony M.¹,Gastaud Lauris¹,Curti Brendan¹,Piulats Josep M.¹,Salama April K.S.¹,Shoushtari Alexander N.¹,Demidov Lev¹,Milhem Mohammed¹,Chmielowski Bartosz¹,Kim Kevin B.¹,Carvajal Richard D.¹,Hamid Omid¹,Collins Laura¹,Ranade Koustubh¹,Holland Chris¹,Pfeiffer Constance¹,Nathan Paul¹

Affiliation:

1. From the University Hospital Heidelberg, Heidelberg (J.C.H.), the Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, Munich (M.S.), and the Department of Dermatology, Venereology, and Allergology (M.S.) and the Department of Hematology, Oncology, and Tumor Immunology and the Comprehensive Cancer Center (S.O.), Charité–Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and the Department of Hematology, Oncology, and Tumor...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2304753

Reference20 articles.

1. Uveal melanoma

2. Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

3. Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis

4. Advances in the clinical management of uveal melanoma

5. Effectiveness of Treatments for Metastatic Uveal Melanoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Non-cutaneous melanoma: new therapeutic insights;Frontiers in Oncology;2024-01-17

2. Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline;Current Oncology;2023-12-20

3. Case Report: Long-term metabolic response of metastatic uveal melanoma to pembrolizumab on FDG-PET/CT despite a serial pseudoprogressions phenomenon;Frontiers in Immunology;2023-12-04

4. Uvea-Melanom: Bispezifischer Antikörper mit überragender Überlebenszeit;Deutsches Ärzteblatt Online;2023-12-01

5. Quoi de neuf en oncodermatologie ?;Annales de Dermatologie et de Vénéréologie - FMC;2023-12